Compare BCTXL & CITR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BCTXL | CITR |
|---|---|---|
| Founded | N/A | N/A |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Environmental Services |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | 2025 | 2008 |
| Metric | BCTXL | CITR |
|---|---|---|
| Price | $0.93 | $5.11 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 13.2K | ★ 29.4K |
| Earning Date | N/A | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $2,381,407.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 194.59 |
| 52 Week Low | $0.61 | $4.35 |
| 52 Week High | $1.40 | $10.37 |
| Indicator | BCTXL | CITR |
|---|---|---|
| Relative Strength Index (RSI) | 51.25 | 39.36 |
| Support Level | $0.92 | $5.10 |
| Resistance Level | $1.11 | $6.21 |
| Average True Range (ATR) | 0.08 | 0.42 |
| MACD | -0.00 | -0.14 |
| Stochastic Oscillator | 46.72 | 9.05 |
BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.